Fair Value Calculator Fair Value Calculator
EN DE

Sunset Island Group (SIGO) Fair Value & Analysis

Healthcare · US · Market cap $592

SI Sunset Island Group logo Sunset Island Group SIGO · US
Price$0.0001
Fair Value$0.0001
Upside+0.0%
Quality54/100
Watch Sunset Island Group for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range $0.0001 – $0.0001

Fair value as of: Jun 26, 2026

From 15 valuation models · updated 7 days ago

Fair value updated Jun 26, 2026 — revised from $2.33 to $0.0001 (−100.0%) since Jun 24, 2026.

Price vs Fair Value (12 months)

$0.0001 $0.0001 Fair Value $0.0001 Jul 2025 Jul 2026

12‑month range $0.0001 – $0.0001 · the $0.0001 price screens below the $0.0001 fair value. As of Jun 26, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Sunset Island Group (SIGO) currently trades at $0.0001, while our model-based Fair Value estimate is $0.0001 — implying the stock looks roughly 0.0% undervalued today. We read business quality at 54/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Net debt stands at $1.6M. Fundamentals as of Jun 26, 2026

Key figures & financial health

Free cash flow $988K FY2021
EPS (TTM) $-0.0100
Net debt $1.6M FY2021

Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.

About the company

Sunset Island Group, Inc., through its subsidiary, VBF Brands, grows, cultivates, manufactures, and distributes cannabis in the United States. It also sells clones. The company is based in Salinas, California.

Revenue & earnings trend

FY2016 – FY2021 · reported fiscal years

Sunset Island Group reported revenue of $2.9M in FY2021 versus $0 in FY2016. Reported net income was −$1.4M in FY2021.

Revenue
FY16 $0
FY17 $0
FY19 $250K
FY20 $1.5M
FY21 $2.9M
Net income
FY17 −$691K
FY18 −$3.3M
FY19 −$3.5M
FY20 −$509K
FY21 −$1.4M

Is SIGO fairly valued? → Check now

Similar stocks

6 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).

Stock Price Fair Value vs Fair Value
Jiangsu Hengrui Pharmaceuticals Co 1276 HK$57.85 HK$29.84 -48%
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,786 ₹991.46 -44%
Zoetis Inc Z1TS34 R$25.93 R$19.70 -24%
Hansoh Pharmaceutical Group 3692 HK$29.30 HK$23.90 -18%
Divi's Laboratories Limited DIVISLAB ₹6,639 ₹1,281 -81%
Swedish Orphan Biovitrum AB SOBI kr 446.60 kr 234.19 -48%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Sunset Island Group (SIGO) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0001 versus a price of $0.0001 — about +0% (undervalued). Model-based estimate, not financial advice.
What is the fair value of SIGO?
Our model-based fair value for Sunset Island Group is $0.0001 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0001.
What is the quality score of SIGO?
Sunset Island Group has a Quality Score of 54/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the net profit margin of SIGO?
The net profit margin of Sunset Island Group is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.